Patent ID: 8658668

Claim:
A method of treating cancer wherein the cancer is selected from the group consisting of bladder cancer, colon cancer, gastric cancer, head and neck cancer, NSCLC, breast cancer, melanoma, ovarian cancer, pancreatic cancer, prostate cancer, glioblastoma, lung cancer, renal cancer, sarcoma, hematopoietic and lymphoid tissue cancer, CNS cancer, cervical cancer, endometrial cancer, liver cancer, skin cancer, stomach cancer, thyroid cancer, upper aerodigestive tract cancer, and urinary cancer, comprising administering to a patient in need thereof an effective amount of a compound which is 8-[5-(1-hydroxy-1-methylethyl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one, or a pharmaceutically acceptable salt thereof.